Cargando…

Ligand modulation of sidechain dynamics in a wild-type human GPCR

GPCRs regulate all aspects of human physiology, and biophysical studies have deepened our understanding of GPCR conformational regulation by different ligands. Yet there is no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR conformations. To address this...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Lindsay D, Dikiy, Igor, Chapman, Karen, Rödström, Karin EJ, Aramini, James, LeVine, Michael V, Khelashvili, George, Rasmussen, Søren GF, Gardner, Kevin H, Rosenbaum, Daniel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650471/
https://www.ncbi.nlm.nih.gov/pubmed/28984574
http://dx.doi.org/10.7554/eLife.28505
_version_ 1783272719821832192
author Clark, Lindsay D
Dikiy, Igor
Chapman, Karen
Rödström, Karin EJ
Aramini, James
LeVine, Michael V
Khelashvili, George
Rasmussen, Søren GF
Gardner, Kevin H
Rosenbaum, Daniel M
author_facet Clark, Lindsay D
Dikiy, Igor
Chapman, Karen
Rödström, Karin EJ
Aramini, James
LeVine, Michael V
Khelashvili, George
Rasmussen, Søren GF
Gardner, Kevin H
Rosenbaum, Daniel M
author_sort Clark, Lindsay D
collection PubMed
description GPCRs regulate all aspects of human physiology, and biophysical studies have deepened our understanding of GPCR conformational regulation by different ligands. Yet there is no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR conformations. To address this deficit, we generated samples of a wild-type GPCR (A(2A)R) that are deuterated apart from (1)H/(13)C NMR probes at isoleucine δ1 methyl groups, which facilitated (1)H/(13)C methyl TROSY NMR measurements with opposing ligands. Our data indicate that low [Na(+)] is required to allow large agonist-induced structural changes in A(2A)R, and that patterns of sidechain dynamics substantially differ between agonist (NECA) and inverse agonist (ZM241385) bound receptors, with the inverse agonist suppressing fast ps-ns timescale motions at the G protein binding site. Our approach to GPCR NMR creates a framework for exploring how different regions of a receptor respond to different ligands or signaling proteins through modulation of fast ps-ns sidechain dynamics.
format Online
Article
Text
id pubmed-5650471
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-56504712017-10-23 Ligand modulation of sidechain dynamics in a wild-type human GPCR Clark, Lindsay D Dikiy, Igor Chapman, Karen Rödström, Karin EJ Aramini, James LeVine, Michael V Khelashvili, George Rasmussen, Søren GF Gardner, Kevin H Rosenbaum, Daniel M eLife Biochemistry and Chemical Biology GPCRs regulate all aspects of human physiology, and biophysical studies have deepened our understanding of GPCR conformational regulation by different ligands. Yet there is no experimental evidence for how sidechain dynamics control allosteric transitions between GPCR conformations. To address this deficit, we generated samples of a wild-type GPCR (A(2A)R) that are deuterated apart from (1)H/(13)C NMR probes at isoleucine δ1 methyl groups, which facilitated (1)H/(13)C methyl TROSY NMR measurements with opposing ligands. Our data indicate that low [Na(+)] is required to allow large agonist-induced structural changes in A(2A)R, and that patterns of sidechain dynamics substantially differ between agonist (NECA) and inverse agonist (ZM241385) bound receptors, with the inverse agonist suppressing fast ps-ns timescale motions at the G protein binding site. Our approach to GPCR NMR creates a framework for exploring how different regions of a receptor respond to different ligands or signaling proteins through modulation of fast ps-ns sidechain dynamics. eLife Sciences Publications, Ltd 2017-10-06 /pmc/articles/PMC5650471/ /pubmed/28984574 http://dx.doi.org/10.7554/eLife.28505 Text en © 2017, Clark et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Biochemistry and Chemical Biology
Clark, Lindsay D
Dikiy, Igor
Chapman, Karen
Rödström, Karin EJ
Aramini, James
LeVine, Michael V
Khelashvili, George
Rasmussen, Søren GF
Gardner, Kevin H
Rosenbaum, Daniel M
Ligand modulation of sidechain dynamics in a wild-type human GPCR
title Ligand modulation of sidechain dynamics in a wild-type human GPCR
title_full Ligand modulation of sidechain dynamics in a wild-type human GPCR
title_fullStr Ligand modulation of sidechain dynamics in a wild-type human GPCR
title_full_unstemmed Ligand modulation of sidechain dynamics in a wild-type human GPCR
title_short Ligand modulation of sidechain dynamics in a wild-type human GPCR
title_sort ligand modulation of sidechain dynamics in a wild-type human gpcr
topic Biochemistry and Chemical Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650471/
https://www.ncbi.nlm.nih.gov/pubmed/28984574
http://dx.doi.org/10.7554/eLife.28505
work_keys_str_mv AT clarklindsayd ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT dikiyigor ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT chapmankaren ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT rodstromkarinej ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT araminijames ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT levinemichaelv ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT khelashviligeorge ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT rasmussensørengf ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT gardnerkevinh ligandmodulationofsidechaindynamicsinawildtypehumangpcr
AT rosenbaumdanielm ligandmodulationofsidechaindynamicsinawildtypehumangpcr